115
Views
21
CrossRef citations to date
0
Altmetric
Original

Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation

, , , &
Pages 437-440 | Received 08 Sep 2005, Accepted 26 Jun 2006, Published online: 07 Jul 2009

References

  • Balasch J, Tur R, Creus M, Buxaderas R, Fabregues F, Ballesca J L, Barri P N, Vanrell J A. Triggering of ovulation by gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecol Endocrinol 1994; 8: 7–12
  • Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004; 81: 1–5
  • Orvieto R. Can we eliminate severe ovarian hyperstimulation syndrome?. Hum Reprod 2005; 20: 320–322
  • Orvieto R, Voliovitch I, Fishman P, Ben-Rafael Z. Interleukin-2 and ovarian hyperstimulation syndrome – a pilot study. Hum Reprod 1995; 10: 24–27
  • Orvieto R, Ben-Rafael Z. Ovarian hyperstimulation syndrome: a new insight into an old enigma. J Soc Gynecol Invest 1998; 5: 110–113
  • Orvieto R. Controlled ovarian hyperstimulation – an inflammatory state. J Soc Gynecol Invest 2004; 11: 424–426
  • Orvieto R, Chen R, Ashkenazi J, Ben-Haroush A, Bar J, Fisch B. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycle. Hum Reprod 2004; 19: 357–359
  • Sacks G P, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks' gestation. Hum Reprod 2004; 19: 1025–1030
  • Thomas L. Labor und Diagnose. 4th ed. Die Medizinische Verlagsgesellschaft, MarburgGermany 1992; 781
  • Almagor M, Hazav A, Yaffe H. The levels of C-reactive protein in women treated by IVF. Hum Reprod 2004; 19: 104–106
  • Orvieto R, Leites T, Abir R, Bar J, Yoeli R, Feldberg D, Fisch B. Interleukin-2 production in whole blood cell cultures of women undergoing controlled ovarian hyperstimulation for assisted reproduction technology cycles. Am J Reprod Immunol 2003; 50: 220–223
  • Kol S, Lewit N, Itskovitz-Eldor J. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications. Hum Reprod 1996; 11: 1143–1144

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.